Immunomodulation Effect of Biomaterials on Bone Formation
Source abstract
Abstract
Traditional bone replacement materials have been developed with the goal of directing the osteogenesis of osteoblastic cell lines toward differentiation and therefore achieving biomaterial-mediated osteogenesis, but the osteogenic effect has been disappointing. With advances in bone biology, it has been revealed that the local immune microenvironment has an important role in regulating the bone formation process. According to the bone immunology hypothesis, the immune system and the skeletal system are inextricably linked, with many cytokines and regulatory factors in common, and immune cells play an essential role in bone-related physiopathological processes. This review combines advances in bone immunology with biomaterial immunomodulatory properties to provide an overview of biomaterials-mediated immune responses to regulate bone regeneration, as well as methods to assess the bone immunomodulatory properties of bone biomaterials and how these strategies can be used for future bone tissue engineering applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Bone and Dental Protein Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing 210029, China
Department of General Practitioners, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
Funding
National Natural Science Foundation of China
References (100+)
Show source-provided references
1. Use of a novel bone graft substitute in peri-articular bone tumours of the knee10.1016/j.knee.2007.07.001 ↗
2. Bone graft substitutes and allografts for reconstruction of the foot and ankle10.1016/j.cpm.2009.07.003 ↗
3. Synthetic bone scaffolds and fracture repair10.1016/j.injury.2007.02.008 ↗
4. Recent Advances in Biomaterials for the Treatment of Bone Defects10.1080/15476278.2020.1808428 ↗
5. Antibacterial biomaterials in bone tissue engineering10.1039/D0TB02983A ↗
6. Recent advances in PLGA-based biomaterials for bone tissue regeneration10.1016/j.actbio.2021.03.067 ↗
7. Biocompatibility of implantable materials: An oxidative stress viewpoint10.1016/j.biomaterials.2016.09.010 ↗
8. Bone versus immune system10.1038/35046196 ↗
9. Inflammatory bone destruction and osteoimmunology10.1111/j.1600-0765.2005.00814.x ↗
10. Immune responses to implants—A review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
11. Nutrient element-based bioceramic coatings on titanium alloy stimulating osteogenesis by inducing beneficial osteoimmmunomodulation10.1039/C4TB00837E ↗
12. Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies10.1016/j.actbio.2021.03.038 ↗
13. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems10.1038/nri2062 ↗
14. Osteoimmunomodulation for the development of advanced bone biomaterials10.1016/j.mattod.2015.11.004 ↗
15. The new bone biology: Pathologic, molecular, and clinical correlates10.1002/ajmg.a.31368 ↗
16. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins10.1016/j.addr.2004.12.016 ↗
17. Collagen sponges for bone regeneration with rhBMP-210.1016/j.addr.2003.08.010 ↗
18. Osteoinductive bone graft substitutes10.1007/PL00008317 ↗
19. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development10.1359/jbmr.060411 ↗
20. Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement10.1152/physiol.00061.2014 ↗
21. Disorders of bone remodeling10.1146/annurev-pathol-011110-130203 ↗
22. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-210.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B ↗
23. BMSC-derived exosomes carrying microRNA-122-5p promote proliferation of osteoblasts in osteonecrosis of the femoral head10.1042/CS20181064 ↗
24. M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 310.1186/s12951-020-00622-5 ↗
25. Roles of Runx2 in Skeletal Development10.1007/978-981-10-3233-2_6 ↗
26. Cbfbeta interacts with Runx2 and has a critical role in bone development10.1038/ng1050 ↗
27. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency10.1002/dvdy.21187 ↗
28. Effect of Runx2 silencing on autophagy and RANKL expression in osteoblasts10.1016/j.archoralbio.2018.07.016 ↗
29. Runx2/Cbfa1: A multifunctional regulator of bone formation10.2174/1381612033453659 ↗
30. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes10.1074/jbc.M006215200 ↗
31. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation10.1016/j.cell.2015.05.029 ↗
32. Osteoclasts and Remodeling Based Bone Formation10.2174/1574888X10666151019115724 ↗
33. Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling10.1007/s10162-019-00727-1 ↗
34. Kim, J.M., Lin, C., Stavre, Z., Greenblatt, M.B., and Shim, J.H. (2020). Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells, 9.10.3390/cells9092073 ↗
35. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells10.1002/jcp.27852 ↗
36. Osteoclast differentiation by RANKL and OPG signaling pathways10.1007/s00774-020-01162-6 ↗
37. A scrutiny of matrix metalloproteinases in osteoclasts: Evidence for heterogeneity and for the presence of MMPs synthesized by other cells10.1016/j.bone.2004.06.019 ↗
38. Matrix metalloproteinase-12 (MMP-12) in osteoclasts: New lesson on the involvement of MMPs in bone resorption10.1016/j.bone.2003.08.011 ↗
39. Senescent immune cells release grancalcin to promote skeletal aging10.1016/j.cmet.2021.08.009 ↗
40. The Effects of Porphyromonas gingivalis on Inflammatory and Immune Responses and Osteogenesis of Mesenchymal Stem Cells10.1089/scd.2021.0068 ↗
41. The Innate Part of the Adaptive Immune System10.1007/s12016-019-08740-1 ↗
42. Osteoimmunology: Evolving concepts in bone-immune interactions in health and disease10.1038/s41577-019-0178-8 ↗
43. Innate and adaptive immune responses to viral infection and vaccination10.1016/j.coviro.2011.07.002 ↗
44. The aging of the immune system10.1111/j.1432-2277.2009.00927.x ↗
45. Hemocompatibility and selective cell fate of polydopamine-assisted heparinized PEO/PLLA composite coating on biodegradable AZ31 alloy10.1016/j.colsurfb.2014.06.036 ↗
46. Integrating immunometabolism and macrophage diversity10.1016/j.smim.2016.10.004 ↗
47. Macrophage plasticity and polarization: In vivo veritas10.1172/JCI59643 ↗
48. Determinants of Resident Tissue Macrophage Identity and Function10.1016/j.immuni.2020.05.014 ↗
49. Targeting macrophages: Therapeutic approaches in cancer10.1038/nrd.2018.169 ↗
50. Microglial M1/M2 polarization and metabolic states10.1111/bph.13139 ↗
51. Macrophage plasticity, polarization, and function in health and disease10.1002/jcp.26429 ↗
52. NLRP3 inflammasome mediates M1 macrophage polarization and IL-1β production in inflammatory root resorption10.1111/jcpe.13258 ↗
53. Mesenchymal stem cell-macrophage crosstalk and bone healing10.1016/j.biomaterials.2017.12.025 ↗
54. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines10.1189/jlb.1A0314-170R ↗
55. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption10.3389/fendo.2020.583561 ↗
56. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages10.1038/emm.2013.135 ↗
57. Histamine up-regulates oncostatin M expression in human M1 macrophages10.1111/bph.14796 ↗
58. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes10.1016/S1471-4906(02)02302-5 ↗
59. M2b macrophage polarization and its roles in diseases10.1002/JLB.3RU1018-378RR ↗
60. Nano-particle mediated M2 macrophage polarization enhances bone formation and MSC osteogenesis in an IL-10 dependent manner10.1016/j.biomaterials.2020.119833 ↗
61. Interleukin-10 inhibits bone resorption: A potential therapeutic strategy in periodontitis and other bone loss diseases
62. Regulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages10.1016/j.biomaterials.2021.120667 ↗
63. Controlled M1-to-M2 transition of aged macrophages by calcium phosphate coatings10.1016/j.biomaterials.2018.07.012 ↗
64. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds10.1016/j.biomaterials.2014.10.017 ↗
65. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype10.1111/sji.12162 ↗
66. Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond10.3389/fimmu.2014.00511 ↗
67. Updating osteoimmunology: Regulation of bone cells by innate and adaptive immunity10.1038/nrrheum.2017.213 ↗
68. Generation mechanism of RANKL+ effector memory B cells: Relevance to the pathogenesis of rheumatoid arthritis10.1186/s13075-016-0957-6 ↗
69. NF-κB-Mediated Regulation of Osteoclastogenesis10.3803/EnM.2015.30.1.35 ↗
70. Th1/Th2 cells10.1097/00054725-199911000-00009 ↗
71. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling10.1084/jem.20082293 ↗
72. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells10.1126/science.aad9272 ↗
73. T Regulatory Cells in Bone Remodelling10.1007/s11914-017-0356-1 ↗
74. The Neutrophil: Constant Defender and First Responder10.3389/fimmu.2020.571085 ↗
75. More friend than foe: The emerging role of neutrophils in tissue repair10.1172/JCI124616 ↗
76. N2-Polarized Neutrophils Guide Bone Mesenchymal Stem Cell Recruitment and Initiate Bone Regeneration: A Missing Piece of the Bone Regeneration Puzzle10.1002/advs.202100584 ↗
77. Regulation of transendothelial neutrophil migration by endogenous interleukin-810.1126/science.1718038 ↗
78. Monocyte and macrophage plasticity in tissue repair and regeneration10.1016/j.ajpath.2015.06.001 ↗
79. The crucial role of neutrophil granulocytes in bone fracture healing10.22203/eCM.v032a10 ↗
80. Mesenchymal lineage cells and their importance in B lymphocyte niches10.1016/j.bone.2017.11.018 ↗
81. Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems10.1152/physrev.00036.2016 ↗
82. Sustaining efficient immune functions with regular physical exercise in the COVID-19 era and beyond10.1111/eci.13485 ↗
83. Tight relationships between B lymphocytes and the skeletal system10.1016/j.molmed.2014.03.003 ↗
84. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: Implications for accelerated osteoclastogenesis in estrogen deficiency10.1359/jbmr.2000.15.7.1321 ↗
85. How B cells influence bone biology in health and disease10.1016/j.bone.2010.06.011 ↗
86. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion10.1016/j.bone.2014.03.052 ↗
87. The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair10.3389/fimmu.2018.00417 ↗
88. Activated B Lymphocyte Inhibited the Osteoblastogenesis of Bone Mesenchymal Stem Cells by Notch Signaling10.1155/2019/8150123 ↗
89. Connection between B lymphocyte and osteoclast differentiation pathways10.4049/jimmunol.167.5.2625 ↗
90. Generation of bone-resorbing osteoclasts from B220+ cells: Its role in accelerated osteoclastogenesis due to estrogen deficiency10.1359/jbmr.2001.16.12.2215 ↗
91. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors10.1016/S8756-3282(03)00097-8 ↗
92. Activation of Macrophages in Response to Biomaterials10.1007/978-3-319-54090-0_13 ↗
93. New insight of immuno-engineering in osteoimmunomodulation for bone regeneration10.1016/j.reth.2021.03.003 ↗
94. Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE(2)-dependent mechanism10.1038/srep38308 ↗
95. Evidence for a cross-talk between human neutrophils and Th17 cells10.1182/blood-2009-04-216085 ↗
96. Neutrophils at the crossroads of innate and adaptive immunity10.1002/JLB.4MIR0220-574RR ↗
97. Calcium phosphate bone graft substitutes: Failures and hopes10.1016/j.jeurceramsoc.2012.02.028 ↗
98. Zinc: Role in immunity, oxidative stress and chronic inflammation10.1097/MCO.0b013e3283312956 ↗
99. Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor κB ligand-induced osteoclast differentiation of murine marcophages10.1016/j.joen.2013.07.004 ↗
100. Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells10.1152/ajpgi.00119.2007 ↗